Literature DB >> 15659022

Analgesic comparison of meloxicam or ketoprofen for orthopedic surgery in dogs.

Aymeric J Deneuche1, Cédric Dufayet, Laurent Goby, Pascal Fayolle, Christophe Desbois.   

Abstract

OBJECTIVE: To compare the safety and efficacy of 2 analgesic protocols (preoperative meloxicam or intraoperative ketoprofen administration) during the first 24 hours after orthopedic surgery in dogs. STUDY
DESIGN: Double-blind, prospective randomized clinical trial. ANIMALS: Sixty client-owned dogs.
METHODS: Dogs with surgical orthopedic disorders were randomly separated into 2 groups: 30 dogs were administered 0.2 mg/kg meloxicam intravenously (IV) immediately before induction and 30 dogs were administered 2 mg/kg ketoprofen IV, 30 minutes before the end of surgery. Pain was assessed with a visual analog scale (VAS) and a cumulative pain score (CPS) preoperatively and at 30 minutes, 1, 2, 3, 4, 6, 8, and 24 hours after extubation. Selected serum biochemical variables were measured before and 24 hours after surgery and, buccal mucosal bleeding time (BMBT) and whole blood clotting time (WBCT) were measured before and 8 hours after surgery. Dogs were anesthetized with propofol and maintained on halothane in oxygen. Any complications were documented for 7 days after surgery. Results were compared between the 2 groups for significant differences in VAS scores (2-sample t-test) and in CPS (Wilcoxon's 2-sample test). Moreover, results were analyzed for significant differences in area under the curve (AUC) for VAS (2-sample t-test) and CPS (Wilcoxon's 2-sample test) among groups. To assess the effects of treatments on biochemical and coagulation functions, pre- and postoperative mean values of BMBT and WBCT were compared within both treatment groups (paired t-tests) and between both groups (2-sample t-test).
RESULTS: No significant differences in pain response or coagulation were found between meloxicam- and ketoprofen-treated dogs. In both groups, alkaline phosphatase and alanine aminotransferase concentrations were significantly increased compared with baseline. No serious complications occurred.
CONCLUSIONS: Preoperative administration of meloxicam is a safe and effective method of controlling postoperative pain for up to 24 hours in dogs undergoing orthopedic surgery. CLINICAL RELEVANCE: Analgesia after administration of preoperative meloxicam was comparable with administration of ketoprofen at the end of the surgery.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15659022     DOI: 10.1111/j.1532-950X.2004.04088.x

Source DB:  PubMed          Journal:  Vet Surg        ISSN: 0161-3499            Impact factor:   1.495


  6 in total

1.  Hemodynamic and behavioral differences after administration of meloxicam, buprenorphine, or tramadol as analgesics for telemeter implantation in mice.

Authors:  Matthew T Rätsep; Valerie F Barrette; Andrew Winterborn; Michael A Adams; B Anne Croy
Journal:  J Am Assoc Lab Anim Sci       Date:  2013-09       Impact factor: 1.232

Review 2.  Analgesic use in nonhuman primates undergoing neurosurgical procedures.

Authors:  Louis DiVincenti
Journal:  J Am Assoc Lab Anim Sci       Date:  2013-01       Impact factor: 1.232

3.  Removing the threat of diclofenac to critically endangered Asian vultures.

Authors:  Gerry Swan; Vinasan Naidoo; Richard Cuthbert; Rhys E Green; Deborah J Pain; Devendra Swarup; Vibhu Prakash; Mark Taggart; Lizette Bekker; Devojit Das; Jörg Diekmann; Maria Diekmann; Elmarié Killian; Andy Meharg; Ramesh Chandra Patra; Mohini Saini; Kerri Wolter
Journal:  PLoS Biol       Date:  2006-01-31       Impact factor: 8.029

4.  Efficacy and safety of deracoxib for the control of postoperative pain and inflammation associated with dental surgery in dogs.

Authors:  Stephen E Bienhoff; Eric S Smith; Linda M Roycroft; Elizabeth S Roberts; Larry D Baker
Journal:  ISRN Vet Sci       Date:  2012-01-23

5.  Clinical efficacy and pharmacokinetics of meloxicam in Mediterranean buffalo calves (Bubalus bubalis).

Authors:  Petra Cagnardi; Jacopo Guccione; Roberto Villa; Luigi D'Andrea; Antonio Di Loria; Maria Carmela Ferrante; Giuliano Borriello; Luigi Zicarelli; Paolo Ciaramella
Journal:  PLoS One       Date:  2017-10-27       Impact factor: 3.240

6.  Pharmacokinetic Evaluation of a Novel Transdermal Ketoprofen Formulation in Healthy Dogs.

Authors:  Halley Gora Ravuri; Nana Satake; Alexandra Balmanno; Jazmine Skinner; Samantha Kempster; Paul C Mills
Journal:  Pharmaceutics       Date:  2022-03-15       Impact factor: 6.321

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.